Search details
1.
Genomic origin, fragmentomics, and transcriptional properties of long cell-free DNA molecules in human plasma.
Genome Res
; 34(2): 189-200, 2024 Mar 20.
Article
in English
| MEDLINE | ID: mdl-38408788
2.
Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs.
Proc Natl Acad Sci U S A
; 120(17): e2220982120, 2023 04 25.
Article
in English
| MEDLINE | ID: mdl-37075072
3.
Epigenetic analysis of cell-free DNA by fragmentomic profiling.
Proc Natl Acad Sci U S A
; 119(44): e2209852119, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36288287
4.
Dual CTLA-4 and PD-1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first-in-human, dose-escalation, and dose-expansion study.
Cancer
; 130(11): 1991-2002, 2024 Jun 01.
Article
in English
| MEDLINE | ID: mdl-38404184
5.
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment.
J Hepatol
; 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-38570034
6.
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 401(10391): 1853-1865, 2023 06 03.
Article
in English
| MEDLINE | ID: mdl-37075781
7.
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Lancet
; 402(10408): 1133-1146, 2023 09 30.
Article
in English
| MEDLINE | ID: mdl-37499670
8.
Organ-specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective study.
Liver Int
; 2024 Apr 15.
Article
in English
| MEDLINE | ID: mdl-38618972
9.
Genome-wide detection of cytosine methylation by single molecule real-time sequencing.
Proc Natl Acad Sci U S A
; 118(5)2021 02 02.
Article
in English
| MEDLINE | ID: mdl-33495335
10.
Detection and characterization of jagged ends of double-stranded DNA in plasma.
Genome Res
; 30(8): 1144-1153, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32801148
11.
Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer).
Future Oncol
; 19(38): 2505-2516, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37671641
12.
Is hepatic resection justified for non-colorectal non-neuroendocrine liver metastases? A systematic review and meta-analysis.
Surgeon
; 21(3): 160-172, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-35718702
13.
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(8): 995-1008, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35798016
14.
Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin.
Genome Res
; 29(3): 418-427, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30808726
15.
Single-Molecule Sequencing Enables Long Cell-Free DNA Detection and Direct Methylation Analysis for Cancer Patients.
Clin Chem
; 68(9): 1151-1163, 2022 09 01.
Article
in English
| MEDLINE | ID: mdl-35587130
16.
Personalized treatment for hepatocellular carcinoma: Current status and future perspectives.
J Gastroenterol Hepatol
; 37(7): 1197-1206, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35570200
17.
Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240.
Cancer
; 127(6): 865-874, 2021 03 15.
Article
in English
| MEDLINE | ID: mdl-33231873
18.
Systemic treatment of hepatocellular carcinoma: An EASL position paper.
J Hepatol
; 75(4): 960-974, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34256065
19.
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.
N Engl J Med
; 379(1): 54-63, 2018 Jul 05.
Article
in English
| MEDLINE | ID: mdl-29972759
20.
Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Gastroenterology
; 2020 May 16.
Article
in English
| MEDLINE | ID: mdl-32428506